Global Phage Therapy Competitive Landscape Professional Research Report 2025

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	170 Pages	DIResearch	January, 2025	DIR19532300

Best Price Guarantee
Price	from $3,500
Length	170 Pages
Publisher	DIResearch
Published Date	January, 2025
SKU	DIR19532300

Global Phage Therapy Competitive Landscape Professional Research Report 2025

Research Summary

Phage therapy is a form of medical treatment that utilizes bacteriophages, which are viruses that infect and kill bacteria, to combat bacterial infections in humans or animals. Bacteriophages are highly specific to particular strains of bacteria, allowing for targeted and precise treatment. In phage therapy, specific phages are selected to match the infectious bacteria, and these phages are then administered to the patient, typically in the form of a phage cocktail. The phages infect and replicate within the bacterial cells, ultimately leading to the destruction of the bacteria. Phage therapy has been explored as an alternative or complementary approach to antibiotics, particularly in cases where antibiotic resistance poses a challenge. While phage therapy has shown promise, it is still an evolving field, and further research is needed to establish its safety and efficacy for widespread clinical use.

According to DIResearch's in-depth investigation and research, the global Phage Therapy market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global manufacturers of Phage Therapy include BiomX (Adaptive Phage Therapeutics), Armata Pharmaceuticals, Phaxiam, Locus, Biosciences, Inc, TechnoPhage, NPO Microgen, MicroMir, Biochimpharm, iNtRON Biotechnology, PrecisioBiotix, Eliava BioPreparations, Intralytix, NexaBiome, CreatiPhage etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Phage Therapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Phage Therapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Phage Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Phage Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Phage Therapy Include:

BiomX (Adaptive Phage Therapeutics)

Armata Pharmaceuticals

Phaxiam

Locus

Biosciences, Inc

TechnoPhage

NPO Microgen

MicroMir

Biochimpharm

iNtRON Biotechnology

PrecisioBiotix

Eliava BioPreparations

Intralytix

NexaBiome

CreatiPhage

Phage Therapy Product Segment Include:

Natural Phages

Synthetic Phages

Phage Therapy Product Application Include:

Animal Health

Human Health

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Phage Therapy Industry PESTEL Analysis

Chapter 3: Global Phage Therapy Industry Porter’s Five Forces Analysis

Chapter 4: Global Phage Therapy Major Regional Market Size and Forecast Analysis

Chapter 5: Global Phage Therapy Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Phage Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Phage Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Phage Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Phage Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Phage Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Phage Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Phage Therapy Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

1 Phage Therapy Market Overview: 1.1 Product Definition and Statistical Scope; 1.2 Phage Therapy Product by Type; 1.2.1 Natural Phages; 1.2.2 Synthetic Phages; 1.3 Phage Therapy Product by Application; 1.3.1 Animal Health; 1.3.2 Human Health; 1.4 Global Phage Therapy Market Size Analysis (2020-2032); 1.5 Phage Therapy Market Development Status and Trends; 1.5.1 Phage Therapy Industry Development Status Analysis; 1.5.2 Phage Therapy Industry Development Trends Analysis
2 Phage Therapy Market PESTEL Analysis: 2.1 Political Factors Analysis; 2.2 Economic Factors Analysis; 2.3 Social Factors Analysis; 2.4 Technological Factors Analysis; 2.5 Environmental Factors Analysis; 2.6 Legal Factors Analysis
3 Phage Therapy Market Porter's Five Forces Analysis: 3.1 Competitive Rivalry; 3.2 Threat of New Entrants; 3.3 Bargaining Power of Suppliers; 3.4 Bargaining Power of Buyers; 3.5 Threat of Substitutes
4 Global Phage Therapy Market Analysis by Regions: 4.1 Phage Therapy Overall Market: 2024 VS 2025 VS 2032; 4.2 Global Phage Therapy Revenue and Forecast Analysis (2020-2032); 4.2.1 Global Phage Therapy Revenue and Market Share by Region (2020-2025); 4.2.2 Global Phage Therapy Revenue Forecast by Region (2026-2032)
5 Global Phage Therapy Market Size by Type and Application: 5.1 Global Phage Therapy Market Size by Type (2020-2032); 5.2 Global Phage Therapy Market Size by Application (2020-2032)
6 North America: 6.1 North America Phage Therapy Market Size and Growth Rate Analysis (2020-2032); 6.2 North America Key Manufacturers Analysis; 6.3 North America Phage Therapy Market Size by Type; 6.4 North America Phage Therapy Market Size by Application; 6.5 North America Phage Therapy Market Size by Country; 6.5.1 US; 6.5.2 Canada
7 Europe: 7.1 Europe Phage Therapy Market Size and Growth Rate Analysis (2020-2032); 7.2 Europe Key Manufacturers Analysis; 7.3 Europe Phage Therapy Market Size by Type; 7.4 Europe Phage Therapy Market Size by Application; 7.5 Europe Phage Therapy Market Size by Country; 7.5.1 Germany; 7.5.2 France; 7.5.3 United Kingdom; 7.5.4 Italy; 7.5.5 Spain; 7.5.6 Benelux
8 China: 8.1 China Phage Therapy Market Size and Growth Rate Analysis (2020-2032); 8.2 China Key Manufacturers Analysis; 8.3 China Phage Therapy Market Size by Type; 8.4 China Phage Therapy Market Size by Application
9 APAC (excl. China): 9.1 APAC (excl. China) Phage Therapy Market Size and Growth Rate Analysis (2020-2032); 9.2 APAC (excl. China) Key Manufacturers Analysis; 9.3 APAC (excl. China) Phage Therapy Market Size by Type; 9.4 APAC (excl. China) Phage Therapy Market Size by Application; 9.5 APAC (excl. China) Phage Therapy Market Size by Country; 9.5.1 Japan; 9.5.2 South Korea; 9.5.3 India; 9.5.4 Australia; 9.5.5 Southeast Asia
10 Latin America: 10.1 Latin America Phage Therapy Market Size and Growth Rate Analysis (2020-2032); 10.2 Latin America Key Manufacturers Analysis; 10.3 Latin America Phage Therapy Market Size by Type; 10.4 Latin America Phage Therapy Market Size by Application; 10.5 Latin America Phage Therapy Market Size by Country; 10.5.1 Mexico; 10.5.2 Brazil
11 Middle East & Africa: 11.1 Middle East & Africa Phage Therapy Market Size and Growth Rate Analysis (2020-2032); 11.2 Middle East & Africa Key Manufacturers Analysis; 11.3 Middle East & Africa Phage Therapy Market Size by Type; 11.4 Middle East & Africa Phage Therapy Market Size by Application; 11.5 Middle East & Africa Phage Therapy Market Size by Country; 11.5.1 Saudi Arabia; 11.5.2 South Africa
12 Competition by Manufacturers: 12.1 Global Phage Therapy Market Revenue by Key Manufacturers (2021-2025); 12.2 Phage Therapy Competitive Landscape Analysis and Market Dynamic; 12.2.1 Phage Therapy Competitive Landscape Analysis; 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales; 12.2.3 Market Dynamic
13 Key Companies Analysis: 13.1 BiomX (Adaptive Phage Therapeutics); 13.1.1 BiomX (Adaptive Phage Therapeutics) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.1.2 BiomX (Adaptive Phage Therapeutics) Phage Therapy Product Portfolio; 13.1.3 BiomX (Adaptive Phage Therapeutics) Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.2 Armata Pharmaceuticals; 13.2.1 Armata Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.2.2 Armata Pharmaceuticals Phage Therapy Product Portfolio; 13.2.3 Armata Pharmaceuticals Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.3 Phaxiam; 13.3.1 Phaxiam Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.3.2 Phaxiam Phage Therapy Product Portfolio; 13.3.3 Phaxiam Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.4 Locus; 13.4.1 Locus Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.4.2 Locus Phage Therapy Product Portfolio; 13.4.3 Locus Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.5 Biosciences, Inc; 13.5.1 Biosciences, Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.5.2 Biosciences, Inc Phage Therapy Product Portfolio; 13.5.3 Biosciences, Inc Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.6 TechnoPhage; 13.6.1 TechnoPhage Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.6.2 TechnoPhage Phage Therapy Product Portfolio; 13.6.3 TechnoPhage Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.7 NPO Microgen; 13.7.1 NPO Microgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.7.2 NPO Microgen Phage Therapy Product Portfolio; 13.7.3 NPO Microgen Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.8 MicroMir; 13.8.1 MicroMir Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.8.2 MicroMir Phage Therapy Product Portfolio; 13.8.3 MicroMir Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.9 Biochimpharm; 13.9.1 Biochimpharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.9.2 Biochimpharm Phage Therapy Product Portfolio; 13.9.3 Biochimpharm Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.10 iNtRON Biotechnology; 13.10.1 iNtRON Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.10.2 iNtRON Biotechnology Phage Therapy Product Portfolio; 13.10.3 iNtRON Biotechnology Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.11 PrecisioBiotix; 13.11.1 PrecisioBiotix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.11.2 PrecisioBiotix Phage Therapy Product Portfolio; 13.11.3 PrecisioBiotix Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.12 Eliava BioPreparations; 13.12.1 Eliava BioPreparations Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.12.2 Eliava BioPreparations Phage Therapy Product Portfolio; 13.12.3 Eliava BioPreparations Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.13 Intralytix; 13.13.1 Intralytix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.13.2 Intralytix Phage Therapy Product Portfolio; 13.13.3 Intralytix Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.14 NexaBiome; 13.14.1 NexaBiome Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.14.2 NexaBiome Phage Therapy Product Portfolio; 13.14.3 NexaBiome Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.15 CreatiPhage; 13.15.1 CreatiPhage Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.15.2 CreatiPhage Phage Therapy Product Portfolio; 13.15.3 CreatiPhage Phage Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
14 Industry Chain Analysis: 14.1 Phage Therapy Industry Chain Analysis; 14.2 Phage Therapy Industry Raw Material and Suppliers Analysis; 14.2.1 Phage Therapy Key Raw Material Supply Analysis; 14.2.2 Raw Material Suppliers and Contact Information; 14.3 Phage Therapy Typical Downstream Customers; 14.4 Phage Therapy Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source: 16.1 Methodology/Research Approach; 16.2 Research Scope; 16.3 Benchmarks and Assumptions; 16.4 Date Source; 16.4.1 Primary Sources; 16.4.2 Secondary Sources; 16.5 Data Cross Validation; 16.6 Disclaimer